4Negi A, Vernon SA. An overview of the eye in diabetes. JR Soc Med, 2003,96:266-272.
5Metascreen Writing Committee, Bonadonna RC, Cucinotta D, et al. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a muhicenter diabetes clinic - based survey. Diabetes Care ,2006,29:2701-2707.
6Van Hecke MV, Dekker JM, Nijpels G, et al. Inflammation and endothelial dysfunction are associated with retinopathy:the Hoom Study. Diabetologia ,2005,48:1300-1306.
7Verna S, Li SH, Wang CH. Hyperglycemia potentiates the proatherogenic effects of C-reactive protein : reversal with resiglitazone. J Mol Cell Cardiol,2003 ,35 :417-419.
